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Abstract	
Background:	Psychological	distress	is	prevalent	in	haemodialysis	(HD)	patients	yet	access	to	
psychotherapy	remains	limited.	This	study	assessed	the	feasibility	and	acceptability	of	
online	cognitive-behavioural	therapy	(CBT)	tailored	for	HD	patients,	with	or	without	
therapist	support,	for	managing	psychological	distress.		
Methods:	This	feasibility	randomised	controlled	trial	recruited	patients	from	a	UK	HD	
centre.	Following	psychological	distress	screens,	patients	with	mild-moderate	psychological	
distress	(Patient	Health	Questionnaire	PHQ-9;	score:	5-19	and/or	Generalised	Anxiety	
Disorder;	GAD-7	score:	5-14)	who	met	remaining	inclusion	criteria	were	approached	for	
consent.	Consenters	were	individually	randomised	(1:1)	to	online-CBT	or	online-CBT	plus	
three	therapist	support	calls.	Outcomes	included	recruitment,	retention,	and	adherence	
rates.	Exploratory	change	analyses	were	performed	for:	psychological	distress,	quality	of	life	
(QoL),	illness	perceptions,	and	costs.	The	statistician	was	blinded	to	allocation.			
Results:	182	(44%)	out	of	410	patients	approached	completed	psychological	distress	
screens.	26%	found	screening	unacceptable;	a	further	30%	found	it	unfeasible.	Psychological	
distress	was	detected	in	101	(55%)	patients,	60	of	these	met	remaining	inclusion	criteria.	
The	primary	reason	for	ineligibility	was	poor	computer	literacy	(N=17,	53%).	Twenty-five	
patients	were	randomised	to	the	supported	(N=18)	or	unsupported	arm	(N=7);	92%	were	
retained	at	follow-up.	No	differences	in	psychological	distress	or	cost-effectiveness	were	
observed.	No	trial	adverse	events	occurred.		
Conclusion:	Online	CBT	appears	feasible	but	only	for	computer	literate	patients	who	identify	
with	the	label	psychological	distress.	A	definitive	trial	using	the	current	methods	for	
psychological	distress	screening	and	online	care	delivery	is	unfeasible.	
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Introduction	1	
Self-reported	psychological	distress,	including	symptoms	of	depression	(1)	and	anxiety	(2),	2	
affects	approximately	39%	of	people	living	with	end-stage	renal	disease	(ESRD)	treated	with	3	
dialysis	(1)	and	is	associated	with	increased	morbidity	(3),	mortality	(4-6),	and	health	care	4	
utilisation	rates	(7).	Identifying	and	treating	psychological	distress	in	haemodialysis	(HD)	5	
patients	remains	a	challenge	(8)	because	effective	and	pragmatic	ways	of	delivering	6	
integrated	mental	and	physical	care	are	yet	to	be	established	in	this	setting.			7	
Identifying	psychological	distress	in	HD	patients	is	the	first	challenge.	Implementing	8	
thorough	psychological	assessment	interviews	is	unfeasible	with	scarce	resource	(9).	Specific	9	
self-report	screens	for	psychological	distress	are	validated	for	use	in	physical	long-term	10	
conditions	(LTCs)	(10)	and	offer	a	practical	solution	for	routine	assessment.	However,	11	
screening	alone	is	insufficient.	Integrated	support	with	evidence-based	treatment	pathways	12	
are	required	to	ensure	patients’	in	need	of	support	are	effectively	managed	at	the	13	
appropriate	level	of	care	(11).	14	
Cognitive	behavioural	therapy	(CBT)	is	an	effective	psychotherapy	for	the	treatment	of	15	
psychological	distress	(12-14).	Three	relatively	small	studies	found	CBT	improved	16	
psychological	distress	outcomes	in	HD	patients	(15-17).	However,	meta-analyses	report	17	
small	effect	sizes	for	CBT	in	people	with	LTCs	(18,	19).	One	reason	for	these	small	effects	18	
may	be	because	CBT	treatments	were	originally	developed	to	treat	primary	mental	health	19	
conditions	(19,	20).	The	application	of	CBT	to	people	with	physical	LTCs	may	require	tailoring	20	
to	ensure	that	factors	unique	to	chronic	illness,	including	maladaptive	and/or	erroneous	21	
perceptions	of	illness	(21)	and	poor	coping	skills	in	response	to	illness	(9)	are	targeted.		NHS	22	
England	pathfinder	work	conducted	within	existing	Improving	Access	to	Psychological	23	
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Therapy	(IAPT)	services	suggested	that	integrating	LTC	self-management	needs	alongside	24	
more	traditional	methods	of	treating	anxiety	and	depression	obtained	larger	treatment	25	
effects	(22).		The	improving	Distress	in	Dialysis	(iDiD)	treatment	is	a	tailored	CBT	protocol	26	
designed	to	manage	psychological	distress	by	providing	patients	with	CBT	skills	which	27	
address	the	psychological	mechanisms	that	perpetuate	distress	in	response	to	28	
haemodialysis	specific	symptom	and	self-management	challenges	(23).		However,	access	to	29	
skilled	psychotherapists	to	support	the	implementation	of	CBT	in	physical	health	contexts	is	30	
limited	(24).	31	
One	method	of	increasing	access	to	CBT	is	via	tailored	online	self-help	programmes.	32	
Therapist	supported	online	CBT	demonstrates	equivalent	efficacy	to	face-to-face	CBT	for	the	33	
management	of	psychological	distress	(25).	In	addition,	online	CBT	has	comparable	34	
adherence	rates	to	psychotherapy	treatment	sessions	when	compared	with	face-to-face	35	
CBT	(26).	Online	CBT	can	be	delivered	using	a	stepped-care	health	service	delivery	model	36	
(27).	According	to	this	model,	individuals	identified	as	having	psychological	distress	are	37	
offered	the	least	restrictive,	yet	most	effective	treatment	first.	The	term	least	restrictive	38	
applies	to	the	intensity	of	support	provided.	Thus	type,	duration,	and	frequency	of	patient-39	
psychotherapist	contact	is	titrated	to	individual	need.		40	
HD	patients	face	a	considerable	treatment	burden,	thus	offering	online	CBT	as	a	first-line	41	
treatment	is	a	pragmatic	solution	for	resource	limited	patients	and	health	services.	42	
Systematic	reviews	suggest	that	providing	therapist	support	alongside	online	CBT	improves	43	
outcomes,	thus	a	degree	of	therapist	input	is	likely	required	(28,	29).	To	inform	a	future	full-44	
scale	randomised	controlled	trial	(RCT),	this	feasibility	study	evaluated	if	HD	specific	online	45	
CBT	(iDiD),	with	or	without	telephone	therapist	support,	is	a	feasible	and	acceptable	46	
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treatment	for	mild	to	moderate	psychological	distress	in	HD	patients.	This	feasibility	RCT	47	
addressed	the	below	quantitative	objectives	to	determine	the	appropriateness	of	the	study	48	
design	for	a	definitive	RCT:		49	
i) Assess	the	feasibility	and	acceptability	of	online	screening	for	symptoms	of	50	
psychological	distress	in	all	patients	attending	for	HD.	51	
ii) Explore	trial	recruitment	and	retention	rates.	52	
iii) Explore	adherence	to	online	CBT	sessions	and	therapist	support	calls	(for	the	53	
purpose	of	this	feasibility	study	adherence	is	defined	as	engagement	with	54	
scheduled	psychotherapy	treatments	sessions	and	does	not	refer	to	adherence	55	
to	dialysis	or	other	treatment	schedules).	56	
iv) Examine	the	potential	efficacy	of	therapist	supported	online	CBT	in	lowering	57	
symptoms	of	psychological	distress	and	improving	quality	of	life	when	compared	58	
with	online	CBT	only.		This	will	allow	an	estimate	of	the	standard	deviation	of	59	
outcomes	to	inform	a	future	power	calculation	for	a	definitive	trial.		60	
v) Study	whether	illness	perceptions	differ	post-intervention	between	the	61	
supported	and	unsupported	online	CBT	arms.	This	will	allow	an	estimate	of	the	62	
standard	deviation	of	illness	perceptions	to	inform	a	future	power	calculation	for	63	
a	definitive	trial.		64	
vi) Examine	preliminary	cost-effectiveness	of	therapist	supported	online	CBT	65	
compared	with	online	CBT	only.		66	
Subjects	and	Methods	67	
Study	Design	and	Participants	68	
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This	two-arm	parallel	group	feasibility	RCT	was	conducted	at	Guy’s	and	St	Thomas	NHS	Trust	69	
(GSTT;	London,	UK)	HD	units	which	treat	approximately	600	HD	patients.	NHS	ethical	70	
approval	for	this	feasibility	study	was	granted	in	December	2014	(reference:	14/LO/1934).	71	
Our	full	study	protocol	is	published	elsewhere	(30).	Patients	were	recruited	and	individually	72	
randomised	to	therapist	supported	online	CBT	or	online	CBT	only	(no	therapist	support)	73	
between	February	2015	and	January	2016.		74	
Patients	were	eligible	for	inclusion	if	they	were	≥	18	years	old,	received	in-centre	HD,	and	75	
had	co-morbid	psychological	distress,	defined	as	mild	to	moderately	severe	symptoms	of	76	
depression	and/or	anxiety.	This	included	a	score	ranging	from	5-19	on	the	Patient	Health	77	
Questionnaire	(PHQ-9)(31)	and/or	a	score	ranging	from	5-14	on	the	Generalised	Anxiety	78	
Disorder	questionnaire	(GAD-7)(32).	Patients	needed	to	speak	English	well	and	have	a	basic	79	
understanding	of	the	internet	and	email	address	to	remain	eligible.	Patients	were	ineligible	80	
if	they	were	receiving	treatment	for	psychological	distress	(active	psychotherapy	or	81	
commenced	pharmacotherapy	within	the	last	three	months),	had	a	severe	mental	health	82	
disorder	(e.g.	psychosis),	or	had	current	suicidal	ideation.		83	
Inclusion	criteria	were	modified	after	three	months	of	recruitment.	Incident	HD	patients	84	
were	found	to	have	greater	motivation	to	participate.	Our	original	protocol	85	
(ClinicalTrials.gov	Identifier-NCT02352870a)	had	the	following	two	exclusion	criteria:	i)	86	
dialysis	vintage	of	≤	three	months	and	ii)	hospitalised	one	month	prior	to	completing	self-87	
																																								 																				
a	Please	note:	Owing	to	a	clerical	error	the	study	was	originally	registered	as	an	
interventional	trial	in	clinicaltrials.gov.	The	correct	option	should	have	been	to	list	this	trial	
as	'other'	to	match	the	content	of	the	registration	document	that	fully	indicates	that	the	
design	of	the	study	is	a	feasibility	trial.	
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report	screen.	These	criteria	were	removed	to	increase	recruitment,	which	is	acceptable	88	
given	the	nature	of	the	study	is	to	assess	feasibility.		89	
Potential	patients	completed	online	self-report	psychological	distress	screens	(31,	32)	whilst	90	
attending	for	HD.	This	occurred		as	part	of	the	Integrating	Mental	and	Physical	healthcare:	91	
research,	training,	and	services	initiative	(IMPARTS)	(33).	Online	screens	were	completed,	92	
either	alone	or	with	nurse/researcher,	using	iPads.	The	screening	process	asked	potential	93	
patients	for	permission	to	contact	them	about	study	participation.	Patients	who:	i)	had	mild-94	
moderately	severe	psychological	distress	symptoms,	ii)	gave	permission	for	research	95	
contact,	and	iii)	met	remaining	inclusion	criteria	were	approached	for	consent.	If	severe	96	
psychological	distress	was	detected	during	screening,	then	the	appropriate	health	care	97	
professional	was	informed.	Figure	1	details	the	stepped-care	model	with	psychological	98	
distress	thresholds	applied	in	this	study	for	onward	referral.		99	
Randomisation,	allocation	concealment,	and	blinding		100	
Consenting	patients	were	individually	randomised	after	completing	the	online	baseline	101	
questionnaire.	Simple	randomisation	occurred	via	Lifeguide	(34)	which	is	a	software	used	to	102	
program	online	interventions.	An	automated	random	number	generator	with	a	1:1	ratio	was	103	
used	to	randomise	patients	to	either	therapist	supported	online	CBT	or	online	CBT	only.	The	104	
patient	was	informed	of	their	group	allocation	via	the	online	CBT	program.	The	patient	and	105	
trial	coordinator	also	received	an	automated	email.	Because	randomisation	was	automated	106	
by	Lifeguide	the	allocation	sequence	remained	concealed	from	the	trial	coordinator	(JLH)	107	
and	psychological	therapists/supervisors	(JLH,	AC).	The	nature	of	the	trial	meant	patients	108	
were	unblinded	to	allocated	treatments.	Follow-up	outcomes	were	completed	by	patients	109	
when	prompted	via	an	automated	email.	It	was	necessary	for	the	research	team	to	110	
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complete	follow-up	measures	with	some	patients	(N=16).	The	statistician	(SN)	remained	111	
blind	to	treatment	allocation	until	after	the	analyses	were	conducted.		112	
Improving	Distress	in	Dialysis	(iDiD)	Intervention		113	
All	patients	had	access	to	the	iDiD	online	intervention.	iDiD	includes	a	seven	session	CBT	114	
protocol	presented	in	detail	elsewhere	(23).	In	brief,	iDiD	targets	specific	cognitive,	115	
emotional,	and	behavioural	mechanisms	associated	with	psychological	distress	in	HD.	116	
Patients	were	encouraged	to	complete	online	sessions	weekly	with	automated	email	117	
reminders.	Sessions	were	designed	to	last	approximately	60	minutes	in	duration.	iPads	were	118	
available	at	dialysis	units	for	on-dialysis	completion.		119	
Supported	arm:	online	CBT	with	therapist	telephone	support	calls	120	
Patients	in	the	supported	arm	received	three	30-minute	telephone	calls	scheduled	at	weeks	121	
two,	four,	and	six	(post-randomisation).	Telephone	support	was	delivered	by	a	trained	122	
psychological	wellbeing	practitioner	(PWP)	with	a	PhD	in	Health	Psychology	(JLH).	PWPs	are	123	
competent	in	the	delivery	of	brief	CBT	interventions	according	to	UK	Improving	Access	to	124	
Psychological	Therapies	curriculum	(35).	Support	calls	aimed	to	promote	engagement	with	125	
the	website	and	CBT	skills	through	a	collaborative	and	empathic	patient-therapist	126	
relationship.	The	PWP	guided	the	patient	to	the	most	relevant	components	of	iDiD	CBT	127	
whilst	also	reviewing	and	problem-solving	progress	collaboratively.	Support	calls	were	audio	128	
recorded	for	clinical	supervision	and	fidelity	checks.		129	
The	PWP	received	training	and	fortnightly	supervision	from	psychologists	(RMM	or	AC).	130	
Supervision	involved	feedback	on	recorded	therapy	sessions	and	case-management	(36).	131	
Patients	identified	as	requiring	more	intensive	clinical	input	were	stepped	up.	132	
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Unsupported	arm:	online	CBT	with	no	therapist	support	calls	133	
The	unsupported	arm	had	access	to	iDiD	CBT	and	usual	renal	care.	Usual	renal	care	includes	134	
attending	for	HD	three	times	per	week.	Whilst	attending	for	dialysis	patients	may	encounter	135	
multidisciplinary	renal	team	members.	Contact	with	the	renal	psychologist	only	occurs	if	a	136	
patient	is	referred	or	self-refers	for	treatment.	None	of	the	patients	allocated	to	the	137	
unsupported	arm	had	contact	with	the	renal	psychologist	prior	to	follow-up.		138	
Outcomes	139	
Feasibility	studies	are	not	powered	to	detect	change	in	a	primary	outcome,	such	as	140	
symptoms	of	psychological	distress.	The	focus	was	to	collect	outcome	data	related	to	trial	141	
design	and	intervention	procedures.	Descriptive	statistics	on	recruitment	and	retention	142	
rates	were	collected,	consistent	with	CONSORT	guidance	(37,	38).	Adherence	to	online	143	
psychotherapy	sessions	and	therapist	support	calls,	including	number	of	completed	calls	and	144	
duration	were	recorded.			145	
Patients	completed	self-report	outcomes	at	baseline	and	12	weeks	post-randomisation.	The	146	
proposed	primary	outcomes	for	the	full-scale	clinical	trial	are	depression	measured	using	147	
the	PHQ-9	(31)	and	anxiety	measured	using	the	GAD-7	(32).	The	PHQ-9	has	a	scale	range	of	148	
0-27;	high	scores	indicate	increased	depressive	symptoms.	It	has	comparable	diagnostic	149	
accuracy	with	longer	clinician	administered	depression	measures	(10).	The	GAD-7	has	a	150	
scale	range	of	0-21	(32).	High	scores	indicate	higher	anxiety.	The	GAD-7	has	evidence	of	151	
diagnostic	accuracy	for	detecting	the	presence	of	generalised	anxiety	disorder	(39)		Quality	152	
of	life	(QoL)	was	measured	using	EuroQoL	scale	(40)(EQ-5D)	and	is	a	proposed	secondary	153	
outcome	for	the	full-scale	trial.	It	includes	five	items	(range,	1-5)	to	assess	mobility,	self-154	
care,	usual	activities,	pain/discomfort,	and	anxiety	and	depression.	High	item	scores	indicate	155	
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poorer	QoL.	The	EQ-5D	also	includes	a	visual	analogue	global	health	rating	(range,	0-100),	156	
high	scores	indicate	better	global	health	ratings.	Intended	mediators	for	the	full-scale	157	
clinical	trial	are	ESRD	illness	perceptions.	Illness	perceptions	were	assessed	using	the	eight	158	
item	Brief	Illness	Perception	Questionnaire	(41).	Each	item	uses	a	10	point	likert	scale.	Item	159	
scores	can	be	summed	to	generate	a	total	illness	perception	score.	High	total	scores	indicate	160	
a	more	negative	perception	of	ESRD.	For	the	health	economic	analyses	the	Client	Service	161	
Receipt	Inventory	(CSRI)	(42)	was	used	to	collect	data	on	health	service	utilisation	combined	162	
with	appropriate	unit	cost	information(43-45).	163	
Demographic	and	Clinical	data		164	
At	baseline,	patients	self-reported	the	following	demographic	and	clinical	data:	gender,	age,	165	
ethnicity,	living	arrangements,	education,	dialysis	vintage	(time	on	dialysis),	and	self-166	
reported	history	of	depression	and/or	anxiety.	Number	and	type	of	co-morbidities	according	167	
to	UK	renal	registry	criteria	-	Appendix	B	(46)	were	extracted	from	clinical	notes.	Data	on	168	
diagnosis	of	depression	and/or	anxiety	was	also	extracted	(if	recorded).		At	follow-up,	169	
patients	were	asked	whether	they	had	experienced	any	adverse	events	during	the	trial	170	
period	(12	weeks)	and	whether	they	had	received	mental	health	treatments	in	addition	to	171	
the	trial.					172	
Sample	size	173	
The	precision	of	the	estimated	screening	to	consent	rate	was	used	to	calculate	the	target	174	
sample	size	because	statistical	power	calculations	are	not	required	for	feasibility	studies	175	
(47).	GSTT	treat	approximately	600	HD	patients.	It	was	anticipated	that	400	patients	would	176	
be	approached	during	recruitment	because	screening	was	facilitated	via	IMPARTS	(33)	177	
online	software	and	not	all	HD	units	were	compatible	with	this	software	(e.g.	privately	178	
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managed	HD	units).	A	conservative	50%	(N=200)	uptake	rate	for	psychological	distress	179	
screening	was	assumed.	With	these	forecasted	proportions,	it	allows	us	to	assess	the	180	
consent	to	screen	rate	(200/400)	to	within	a	standard	error	of	±	5%,	based	on	95%	181	
confidence	intervals.	From	the	population	of	patients	screened	(N=200)	a	further	40%	182	
(N=80)	were	estimated	to	meet	criteria	for	psychological	distress	(based	on	previous	183	
prevalence	estimates)	(1)).	A	conservative	50%	consent	to	trial	rate	(N=40)	from	the	eligible	184	
pool	of	participants	was	assumed	(40/80).	With	these	forecasted	values	we	are	able	to	185	
estimate	a	50%	consent	to	trial	rate	(from	those	meeting	all	eligibility	criteria)	to	within	a	186	
standard	error	of	±	11%,	based	on	95%	confidence	intervals.	Likewise,	our	total	population	187	
trial	consent	rate	of	10%	(e.g.	40/400)	can	be	estimated	to	within	a	standard	error	of	±	3%,	188	
based	on	95%	confidence	intervals.	However,	we	aimed	to	achieve	a	higher	sample	size	189	
within	the	region	of	66	given	that	our	previous	research	in	the	dialysis	achieved	a	consent	to	190	
study	rate	within	the	region	of	80%	when	assessing	depression	on	dialysis	(48).		191	
Analysis		192	
Descriptive	statistics	were	used	to	quantify	screening,	recruitment,	retention	and	adherence	193	
rates.	Adherence	to	psychotherapy		was	conservatively	defined	whereby	everyone	was	194	
included	in	the	analysis	based	on	their	condition	assigned,	unless	a	patient	became	195	
deceased	during	the	trial	(26).	Linear	regression	analysis	controlling	for	baseline	scores	were	196	
used	to	compare	depression,	anxiety,	QoL,	and	illness	perception	outcomes	between	the	197	
supported	and	unsupported	arm	at	12	weeks	follow-up.	Because	this	is	a	feasibility	study	198	
and	consistent	with	latest	CONSORT	guidelines	for	feasibility	studies,	we	report	effect	sizes	199	
and	their	precision	only	(e.g.	standard	error	and	95%	confidence	intervals)(38,	47).	Cost-200	
effectiveness	analyses	used	a	healthcare	perspective.	The	cost	of	the	intervention	was	201	
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calculated	as	the	cost	of	developing	and	maintaining	the	iDiD	online	CBT	programme	202	
(assumed	to	be	£1000	if	rolled	out)	plus	telephone	and	email	support	costs	(therapist	203	
supported	arm).	The	email	and	telephone	support	was	provided	by	a	PWP,	with	a	PhD,	thus	204	
unit	costs	were	based	on	£86	per	hour	of	direct	contact,	equivalent	to	a	CBT	therapist	(43).	205	
Other	service	use	was	measured	with	the	CSRI.	The	main	outcome	measure	for	the	206	
economic	analysis	was	quality-adjusted	life	years	(QALYs)	derived	from	an	EQ-5D	value	set	207	
for	England	(49).	Incremental	cost	effectiveness	ratios	(ICERs)	and	QALYs	were	calculated	208	
using	regression	models	with	follow-up	costs	and	QALYs	as	dependent	variables,	controlling	209	
for	treatment	group,	baseline	costs	and	EQ-5D	score.	210	
Results		211	
Feasibility	of	screening,	recruitment	rates,	and	baseline	sample	characteristics	212	
A	total	of	410	HD	patients	were	approached	to	complete	psychological	distress	screens,	of	213	
which	182	(44.4%;	95%	CI	39.5%	to	49.3%)	agreed	(Figure	2).		Many	patients	(N=115,	63.2%;	214	
95%	CI	55.7%	to	70.2%)	required	assistance	to	complete	the	screen.	Reasons	for	screen	non-215	
completion	included	either	pragmatic/external	barriers	(e.g.	language,	illness)	or	216	
internal/patient	generated	barriers	(e.g.	non-disclosure	of	decline	reason,	lack	of	perceived	217	
need	for	distress	screen).	Pragmatic/external	barriers	prevented	screening	in	121	patients	218	
(29.5%;	95%	CI	25.1%	to	34.2%)	whilst	patient	generated	barriers	prevented	screening	in	219	
107	patients	(26.1%;	95%	CI	21.9%	to	30.6%).		220	
Among	the	182	patients	who	completed	the	screen,	a	total	of	101	patients	(55.5%;	95%	CI	221	
47.9%	to	62.8%)	had	mild-moderately	severe	symptoms	of	psychological	distress.	Of	these	222	
101	patients,	a	further	60	(59.4%;	95%	CI	49.2%	to	69.1%)	met	remaining	inclusion	criteria.	223	
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Poor	computer	literacy	(N=17,	59.4%;	95%	CI	49.2%	to	69.1%)	was	the	main	reason	for	study	224	
ineligibility.	Figure	2	provides	further	ineligibility	details.		225	
Of	the	60	patients	meeting	the	eligibility	criteria	that	were	approached	for	consent,	35	226	
(58.3%;	95%	CI	44.9%	to	70.9%)	declined.	The	main	reason	for	non-consent	was	a	perceived	227	
lack	of	treatment	need	(N=15;	42.8%;	95%	CI	26.3%	to	60.6%;	See	Figure	2	for	details).		A	228	
total	of	25	patients	consented	and	were	randomised	to	either	online	CBT	with	therapist	229	
support	calls	(N=18;	72%)	or	online	CBT	only	(N=7;	28%).	It	was	necessary	to	approach	16	230	
patients	for	screening	for	every	one	patient	randomised	(410/25=16.4;	95%	CI	11.1	to	25.3).	231	
The	consent	to	trial	rate	was	41.7%	among	those	meeting	all	trial	inclusion	criteria	(25/60;	232	
95%	CI	29.1	to	55.1).		233	
Patients	who	consented	to	be	randomised	(N=25)	had	a	mean	age	of	48	(SD	12.01)	years	234	
and	were	predominantly	male	(60%)	of	non-white	ethnicity	(60%).	The	sample	had	a	mean	235	
dialysis	vintage	of	26.52	(SD	=	1.16)	months	and	a	mean	of	1.16	(SD	1.21)	comorbidities.	236	
Depression	scores	at	baseline	indicated	the	presence	of	mild	depressive	symptoms	(Median	237	
=	7;	Interquartile	range	IQR=	4-10).	Median	anxiety	scores	at	baseline	were	considered	sub-238	
threshold	for	symptoms	of	anxiety	(<	5)	(median	=	4,	IQR	=	1-5).	See	tables	one	and	two	for	239	
baseline	sociodemographic,	clinical,	and	self-report	descriptive	statistics.		240	
Adherence	to	online	intervention	and	telephone	support	calls		241	
Adherence	to	online	CBT	sessions	were	lower	for	patients	randomised	to	the	supported	arm	242	
(Median=3,	IQR=1-5)	compared	with	the	unsupported	arm	(Median=6;	IQR	range=2-6).	243	
Table	A	–	online	appendix	summarises	adherence	to	each	of	the	seven	sessions.	On-dialysis	244	
completion	was	the	preferred	location	for	engaging	with	iDiD	CBT	in	both	trial	arms.		Table	B	245	
–	online	appendix	summarises	the	degree	of	adherence	to	the	telephone	support	calls	and	246	
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reasons	for	non-completion;	53%	of	patients	completed	two	or	more	scheduled	support	247	
calls.			248	
Protocol	deviations	occurred	in	both	trial	arms.		It	was	necessary	to	generate	an	email	249	
address	and	provide	brief	internet	education	for	six	patients	(24%	of	consented	sample;	250	
supported	arm	N=5,	unsupported	arm	N=1),	thus	these	patients	received	a	higher	degree	of	251	
technical	support	and	face	to	face	contact.	One	patient	in	the	supported	arm	was	unable	to	252	
receive	therapist	calls	because	of	their	intensive	home-care	program	(e.g.	carers	present)	253	
and	associated	multimorbidity.	On-dialysis	support	was	provided	for	this	patient.		254	
Comparison	of	self-report	outcomes	between	the	supported	and	unsupported	arms	at	12	255	
weeks	follow-up	256	
In	terms	of	trial	retention	rates,	23	(92.0%;	95%	CI	73.5%	to	99.0%)	patients	completed	257	
depression	and	anxiety	outcomes	at	follow-up.		Follow-up	data	was	collected	between	June	258	
2015	and	May	2016.	259	
Table	three	summarises	preliminary	analyses	exploring	trends	in	treatment	effects	260	
comparing	therapist	supported	online	CBT	with	online	CBT	only.	Given	the	study	was	not	261	
powered	to	detect	differences,	significance	testing	was	not	performed	and	the	treatment	262	
effect	estimates	are	provided	for	descriptive	reasons	only	and	to	guide	the	design	of	a	263	
future	definitive	trial.	Cohen’s	d	effect	size	estimates	indicate	that	the	difference	between	264	
the	supported	and	unsupported	arm	on	measures	of	depression	and	anxiety	were	minimal	265	
with	large	confidence	intervals,	highlighting	the	uncertainty	around	this	effect	size	estimate.	266	
Pre-post	mean	change	analysis	across	the	whole	sample	indicated	that	mean	depression	267	
scores	increased	by	0.39	(SD	=	3.99;	scale	range	0-27)	and	mean	anxiety	scores	decreased	by	268	
-0.61	(SD	4.97;	scale	range	0-21)	269	
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Effect	sizes	for	QoL	showed	greater	improvements	in	the	supported	arm	when	compared	270	
with	the	unsupported	arm	across	the	five	QoL	items	(see	table	three)	and	the	visual	271	
analogue	overall	health	rating.	The	largest	effects	(Cohen’s	d	≥	0.80)	were	observed	for	272	
mobility,	pain,	and	usual	daily	activities	items.	However,	confidence	intervals	for	these	273	
estimates	were	large	demonstrating	uncertainty	around	these	findings.		274	
Compared	with	the	unsupported	arm,	patients	in	the	supported	arm	showed	an	improved	275	
illness	related	appraisal	of	ESRD	in	4	out	of	8	of	the	illness	perception	subscales,	with	276	
moderate	effect	sizes	(Cohen’s	d	within	the	region	of	0.50;	see	table	three).	This	included	277	
personal	control,	illness	coherence,	illness	concerns,	and	identity	domains.		However,	278	
patients	in	the	supported	arm	also	reported	having	a	more	negative	emotional	response	to	279	
ESRD	compared	with	the	unsupported	arm.	Confidence	intervals	for	these	estimates	were	280	
large	highlighting	uncertainty.		281	
Adverse	events	and	other	potential	harms	282	
A	total	of	10	adverse	events	were	detected.	None	were	deemed	related	to	the	study.	An	283	
additional	two	events	occurred	that	the	study	team	were	unaware	of	and	were	self-284	
reported	by	patients.	Both	included	a	hospital	admission	related	to	a	routine	renal	285	
procedure	(e.g.	fistulaplasty).	Two	patients	scores	indicated	the	presence	of	suicidal	286	
ideation	in	response	to	questions	concerning	“Thoughts	you	would	be	better	off	dead	or	287	
harming	yourself.”	at	follow-up.	These	patients	were	immediately	contacted	and	a	risk	288	
assessment	was	performed.	These	responses	occurred	because	patients	completed	289	
questionnaires	whilst	attending	for	dialysis,	which	acted	as	a	trigger	for	their	low	mood	and	290	
feelings	of	exasperation.		Excluding	the	two	patients	in	which	suicidal	ideation	was	detected	291	
no	patients	met	criteria	for	onward	referral	for	a	step	three	or	four	intervention	at	follow-up	292	
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as	outlined	in	Figure	1.	One	patient	expressed	an	interest	in	seeking	to	continue	their	293	
treatment	gains	in	response	to	iDiD	with	further	face-to-face	input	from	clinical	psychology	294	
and	an	onward	referral	was	made.	A	fourth	patient	also	expressed	an	interest	in	receiving	295	
face-to-face	input	after	finding	it	difficult	to	logon	and	use	the	iDiD	online	treatment	–	this	296	
patient	also	received	an	onward	referral	to	renal	clinical	psychology.		297	
Cost-effective	analysis	298	
Service	use	at	baseline	was	different	between	the	two	groups	(Table	C	online	appendix).	The	299	
mean	cost	of	the	intervention	was	£40	for	the	unsupported	arm,	and	£244	for	the	300	
supported	arm.	The	follow-up	healthcare	costs	adjusted	for	baseline	were	£2,271	higher	for	301	
the	supported	arm,	but	with	the	small	numbers	(n	=	16)	this	was	not	significant	(95%	C.I.	£-302	
2,766	to	£7,307).	At	follow-up,	the	unsupported	arm	gained	0.144	QALYs,	and	the	supported	303	
arm	gained	0.192	QALYs.	Adjusting	for	baseline	utility	the	supported	arm	had	0.0276	more	304	
QALYs	than	the	unsupported	group	(95%	C.I.,	0.0107	to	0.0444).	The	ICER	was	£2271	divided	305	
by	0.0276,	i.e.	£82,283	per	QALY	albeit	with	wide	confidence	intervals	(95%	CI	£51,	149	–	306	
£212,	243).	307	
Discussion		308	
This	study	reports	on	the	feasibility	and	acceptability	of	implementing	tailored	online	CBT	309	
for	psychological	distress,	with	or	without	therapist	support,	in	HD	patients.	The	study’s	310	
methods	for	proactively	identifying	and	subsequently	managing	psychological	distress	in	HD	311	
identified	a	disproportionately	large	screen	to	trial	consent	rate	ratio	(16:1),	when	312	
compared	with	previous	CBT	feasibility	studies	in	HD	(15-17).		Challenges	to	recruitment	313	
were	accounted	for	by	three	factors:	i)	low	levels	of	patient	acceptability	of	screening	for	314	
psychological	distress,	ii)	low	levels	of	computer	literacy,	and	iii)	lack	of	perceived	treatment	315	
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need	for	psychological	support.	As	such,	this	study	did	not	recruit	to	its	intended	target	of	316	
66	patients.	The	study	was	terminated	once	it	had	exhausted	all	of	its	intended	recruitment	317	
sampling	frames	within	Guy’s	and	St	Thomas’	HD	units.	Furthermore,	adherence	to	online	318	
treatment	sessions	was	low.	In	addition,	exploratory	effect	size	estimates	for	the	intended	319	
primary	outcomes	for	a	full-scale	trial	did	not	suggest	a	trend	for	improved	psychological	320	
distress	outcomes	or	cost-effectiveness	for	patients	randomised	to	the	supported	arm	321	
compared	with	the	unsupported	arm.	These	findings	suggest	the	need	for	revisions	to	322	
current	trial	design	before	a	future	definitive	trial	is	implemented.	The	suggested	revisions	323	
are	discussed	below.		324	
Recruitment	325	
A	56%	psychological	distress	screen	refusal	rate	was	observed.	This	refusal	rate	is	much	326	
higher	than	the	3%	refusal	rate	observed	by	Duarte	et	al’s	small	CBT	trial	for	depression	(15)	327	
and	is	high	compared	with	screen	refusal	rates	observed	in	other	secondary	care	LTC	328	
contexts	using	similar	screening	methods	(33).		Nonetheless,	the	observed	refusal	rate	is	329	
marginally	higher	than	the	forecasted	50%	screen	refusal	rate.	A	quarter	of	all	patients	330	
approached	for	screening	found	it	unacceptable	in	HD	settings.		It	is	likely	that	the	perceived	331	
acceptability/normalisation	of	screening	is	influenced	by	the	context	in	which	it	is	332	
introduced	to	the	patient.	An	alternative	approach	to	detecting	psychological	distress	may	333	
seek	to	embed	screening	procedures	early	on	in	a	patients	HD	care	pathway	so	that	parity	of	334	
esteem	is	achieved	between	mental	and	physical	health	outcomes,	in	effect	normalising	the	335	
process	(24).			336	
Whilst	the	trial	identified	a	higher	than	anticipated	prevalence	of	psychological	distress	(55%	337	
compared	with	an	estimated	40%),	once	the	remaining	inclusion	criteria	were	applied	a	338	
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smaller	than	anticipated	number	of	participants	were	eligible	for	approach	for	consent	into	339	
the	trial.	The	main	reason	for	study	ineligibility	among	patients	meeting	psychological	340	
distress	thresholds	was	poor	computer	literacy.	Recruitment	rates	may	be	improved	if	341	
alternative	forms	of	the	iDiD	CBT	intervention	are	made	available	(e.g.	written	manuals).		342	
Among	patients	meeting	all	study	inclusion	criteria,	over	a	third	found	online	CBT	343	
inappropriate	for	their	needs,	thus	resulting	in	a	lower	than	expected	consent	to	trial	rate.	344	
One	main	contributor	to	this	low	perceived	need	was	the	low	symptom	thresholds	used	to	345	
define	the	presence	of	psychological	distress	resulting	in	false-positive	screens.	A	future	trial	346	
may	consider	implementing	a	second	screen	for	psychological	distress	after	a	fortnightly	347	
interval	has	elapsed.	This	will	allow	patients	with	persistent	symptoms	of	distress	to	be	348	
identified	(50).	This	likewise	may	be	a	useful	strategy	to	apply	in	secondary	care	physical	349	
health	setting	with	limited	mental	health	resources.			Nonetheless,	the	study’s	consent	to	350	
trial		rate	from	patients	meeting	all	study	inclusion	criteria	is	comparable	with	a	median	351	
uptake	rate	of	38%	identified	from	a	meta-analysis	of	online	depression	and	anxiety	352	
interventions	(51).	Thus,	barriers	to	online	CBT	are	not	unique	to	HD	patients.		353	
Treatment	Adherence	354	
Adherence	to	online	treatment	sessions	across	both	arms	were	lower	than	those	reported	355	
in	other	studies	of	online	CBT	for	depression	(26).	Sustaining	adherence	to	psychotherapy	in	356	
multimorbid	populations	is	identified	as	a	key	challenge	but	precisely	what	constitutes	an	357	
active	“dose”	of	psychotherapy	remains	unanswered	(52-54).	A	greater	time	interval	358	
between	scheduled	therapy	sessions	may	benefit	patients	with	multimorbidty	because	their	359	
competing	treatment	demands	may	become	more	dispersed	over	time.		This	study	also	360	
observed	higher	adherence	rates	in	the	unsupported	arm.	This	conflicts	with	meta-analytic	361	
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findings	which	report	the	benefit	of	therapist	supported	online	interventions	for	sustaining	362	
adherence	(29).	However,	the	meta-analysis	also	demonstrated		that	type	of	support	363	
provided	(therapeutic	vs	administrative)	had	no	impact	on	online	adherence	rates	(29).	The	364	
majority	of	patients	in	this	study	were	provided	with	iPads	by	the	study	team	whilst	365	
receiving	HD,	which	is	comparable	to	administrative	support.	Indeed,	a	quarter	of	all	366	
randomised	patients	required	brief	training	in	the	use	of	iPads/Internet.	A	future	definitive	367	
trial	needs	to	take	steps	to	ensure	the	amount	of	support	provided	to	patients	is	368	
standardised	within	and	across	each	arm	if	on-dialysis	access	to	self-help	CBT	is	provided.			369	
Preliminary	effects	size	estimates	370	
This	study	found	no	differences	between	the	supported	and	unsupported	arm	on	371	
psychological	distress	outcomes	which	contradicts	previous	small	scale	CBT	studies	in	HD	372	
(15-17).		However,	two	of	these	past	trials	(15,	16)	recruited	patients	with	higher	baseline	373	
depression	scores	compared	with	the	thresholds	used	here,	overcoming	the	potential	for	374	
floor	effects.	Whilst	the	third	study	used	clinical	thresholds	for	depression	and	anxiety	that	375	
were	comparable	to	this	study,	its	sample	had	higher	baseline	scores	for	depression	and	376	
anxiety,	likewise	overcoming	the	potential	for	floor	effects	(17).	A	future	definitive	trial	and	377	
likewise	secondary	care	treatment	setting	with	limited	resource	for	psychological	care	may	378	
consider	using	a	higher	baseline	criteria	for	defining	the	presence	of	clinically	significant	379	
symptoms	of	psychological	distress.		The	findings	from	this	study	make	a	power	calculation	380	
for	a	definitive	randomised	controlled	trial	challenging	because	of	the	absent	treatment	381	
effect.		382	
Exploratory	statistical	findings	allude	to	the	added	benefit	of	therapeutic	support	for	383	
improving	QoL	outcomes.	This	finding	is	consistent	with	three	previous	studies	of	CBT	in	HD	384	
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(15-17).	Observed	improvements	in	QoL	may	relate	to	patients	in	the	supported	arm	385	
experiencing	greater	improvements	in	their	ESRD	illness	perception	(e.g.	increased	illness	386	
understanding	and	perceptions	of	control	and	a	decreased	ESRD	symptom	burden	and	387	
illness	related	concerns).	It	should	be	noted	however,	that	patients	in	the	supported	arm	388	
also	reported	that	their	ESRD	affected	them	more	emotionally	(BIPQ	–	emotional	response	389	
item).	It	may	be	that	the	telephone	support	calls	prompted	patients	to	recognise	their	390	
emotional	response	to	HD	more	readily.	These	effect	size	estimates	need	to	be	interpreted	391	
cautiously	because	of	the	small	sample	size,	unevenly	distributed	groups,	absence	of	392	
statistical	power,	and	aggregate	level	data	analysis.		However,	it	may	be	the	case	that	iDiD	393	
CBT	is	more	suited	to	addressing	illness	self-management	challenges	and	improving	QoL	as	394	
opposed	to	treating	diagnosable	depression	and	anxiety	disorders.	395	
Exploratory	cost-effectiveness	analyses	showed	the	supported	arm	had	higher	costs	and	396	
more	QALYs	than	the	unsupported	arm	(online	CBT	only).	The	cost	per	QALY	(£82,283)	was	397	
beyond	the	£20,000-£30,000	NICE	threshold	which	is	applied	to	recommend	new	398	
interventions	(55).		The	inflated	costs	in	the	supported	arm	are	accounted	for	by	an	399	
increased	rate	of	inpatient	hospital	admissions	compared	with	the	unsupported	arm,	which	400	
was	likely	an	artefact	of	the	unevenly	distributed	sample	size.	Nonetheless,	the	findings	401	
highlight	that	it	is	feasible	to	collect	health	service	costs	within	this	patient	population.			402	
Strengths	and	limitations	403	
This	is	the	first	feasibility	RCT	of	online	CBT	for	the	management	of	psychological	distress	in	404	
UK	HD	patients.	An	ethnically	diverse	sample	was	recruited	which	represented	the	ethnic	405	
profile	of	patients	who	attend	London	HD	treatment	centres	(46).	Our	detailed	descriptive	406	
recording	of	reasons	for	study	non-consent	permits	us	to	comprehensively	inform	the	407	
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planning	of	the	future	full-scale	trial	to	increase	recruitment	rates.	Indeed,	once	a	patient	408	
consented	into	the	study	we	were	able	to	achieve	a	robust	retention	rate.		Limitations	409	
include	a	sample	mean	age	that	is	lower	than	the	national	mean	age	of	individuals	who	410	
commence	HD	(46).	However,	this	is	likely	because	of	the	web-based	nature	of	the	411	
intervention.	Second,	simple	randomisation	was	used;	because	the	recruited	sample	size	412	
was	smaller	than	planned	an	uneven	distribution	of	patients	occurred	across	the	two	study	413	
arms.	Randomisation	procedures	for	our	full-scale	trial	need	amending	to	include	block	414	
randomisation	procedures	to	minimise	the	risk	of	unevenly	distributed	groups	(56).	Third,	415	
interpretation	of	our	statistical	analyses	requires	a	high	level	of	caution.	Because	this	is	a	416	
feasibility	study	our	analyses	were	not	statistically	powered	to	detect	clinically	meaningful	417	
change	in	outcomes.	In	addition,	our	small	sample	size	means	that	our	effect	size	estimates	418	
lack	precision.	Findings	identified	in	our	study	may	not	translate	to	a	fullscale	trial.	Fourth,	419	
our	feasibility	study	did	not	include	a	measure	of	cognitive	impairment	which	is	prevalent	in	420	
the	HD	population	(57).	Whilst	we	excluded	patients	with	severe	mental	health	disorders	421	
(including	dementia),	we	did	not	proactively	examine	the	role	of	cognitive	function	and	its	422	
potential	to	impact	on	adherence	to	the	online	intervention.	This	is	likely	an	important	423	
moderator	for	inclusion	in	a	future	full-scale	trial.	424	
Implications	for	future	trials	and	clinical	practice	425	
This	study	has	identified	that	the	current	trial	design	is	unfeasible	and	a	number	of	426	
necessary	revisions	are	needed.	First,	there	is	a	need	to	negotiate	an	acceptable	illness	label		427	
to	define	psychological	distress	in	HD	which	mirrors	the	patients	lived	experience	(58,	59)	428	
whilst	also	considering	the	contextual	introduction	of	proactive	psychological	distress	429	
management	strategies	to	promote	normalisation	(60).	Second,	whilst	online	self-help	430	
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treatments	provide	increased	opportunities	for	tailoring		treatment	content	to	individual	431	
need	(61),	it	is	a	barrier	to	accessing	care	among	those	with	low	computer	literacy.	Thus	432	
different	self-help	treatment	modalities	including	written	bibliotherapy	resources	are	433	
needed	to	promote	access	to	care	and	improve	recruitment	to	guided	self-help	trials.	Third,	434	
consideration	of	the	entry	criteria	into	psychological	distress	trials	and	likewise	entry	and	435	
progression	through	psychological	care	pathways	in	LTC	settings	is	needed.	In	the	trial	436	
context,	if	entry	criteria	are	too	low	the	capacity	to	demonstrate	change	in	psychological	437	
distress	outcomes	is	hampered.	In	the	haemodialysis	care	context,	if	low	clinical	thresholds	438	
are	used,	then	limited	resource	may	be	diverted	away	from	those	with	the	highest	degree	of	439	
clinical	need	(11,	62).	Fourth,	low	adherence	to	the	online	sessions	ma	have	occurred	440	
because	online	treatments	sessions	were	too	intense	for	patients	whom	are	simultaneously	441	
negotiating	HD	symptoms	and	self-management	tasks.	Shortening	the	content	of	the	online	442	
sessions	and/or	increasing	the	post-intervention	follow-up	period	will	provide	increased	443	
opportunities	to	engage	with	the	treatment.	The	above	revisions	may	be	incorporated	444	
within	a	nested	pilot	study	with	strict	“go	no-go”	criteria	to	monitor	progress	before	a	445	
definitive	multicentre	trial	is	implemented.		446	
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Table	1:	Baseline	sociodemographic	and	clinical	characteristics	and	scores	on	self-report	questionnaires	for	patients	who	consented	into	the	study	(N=25)	
Variable	 Supported	Arm	(N=18)		 	 Unsupported	Arm	(N=7)	
	 Mean/Frequency	(Standard	Deviation/%)	 	 Mean/Frequency	(Standard	Deviation)/%)	
Gender/proportion	of	males		 10	(56)	 	 5	(71)	
Age/years	 49	(11.44)	 	 47	(14.25)	
Ethnicity/proportion	of	white	ethnicity		 6	(33)	 	 4	(57)	
Living	arrangements/proportion	living	alone		 5	(27)	 	 1	(14)	
Education	status/proportion	with	no	higher/university	education		 14	(78)	 	 3	(43)	
Mean	number	of	comorbidities2	 1.06		(1.16)		 	 1.43	(1.39)	
Dialysis	vintage/months	 23.72	(30.14)		 	 33.70	(26.80)	
Prior	depression	treatment		 5	(26)	 	 1	(14)	
Prior	anxiety	treatment	 2	(11)		 	 1	(14)	
Primary	renal	diagnosis	(self-report)		 	 	 	
Diabetes	 3	(16)	 	 1	(14)	
Hypertension	 6	(34)		 	 2	(29)	
Other	 9	(50)		 	 4	(57)		
																																								 																				
2	Includes	sum	of	the	following	related	conditions:	coronary	heart	disease,	cerebrovascular	disease,	diabetes,	lung/chronic	obstructive	pulmonary	disease,	liver	disease,	cancer,	
peripheral	vascular	disease,	depression	and/or	anxiety:	range	0	–	8	long-term	conditions.		
Improving	Distress	in	Dialysis:	a	feasibility	RCT	–	AUTHOR	ACCEPTED	MANUSCRIPT	19/09/17	(UNCORRECTED	PROOF)	
29	
	
Table	2:	Descriptive	statistics	for	primary	and	secondary	outcomes	at	baseline	and	12	weeks	follow-up	for	the	supported	and	unsupported	therapy	arms		
	
	 Supported	arm	 	 Unsupported	arm	
	 Baseline	(N=18)	 Follow-up	(N=See	key)	 	 Baseline	(N=7)	 Follow-up	(N=See	key)	
Self-report	questionnaires	 Mean/	Frequency	
(SD/%)		
Median	
(Interquartil
e	range)		
Follow-up	
Mean/Frequency	
(SD/%)	
Median	
(Interquartile	
range)	
	 Baseline	Mean/	
Frequency		
(SD/%)	
Median	
(Interquartile	
range)	
Follow-up	
Mean/Frequenc
y	
(SD/%)	
Median	
(Interquartile	
range)	
Point	of	screen	 	 	 	 	 	 	 	 	 	
Depression	(PHQ-9)	 8.89	(4.17)	 8.5	(6-12)		 NA	 	 	 8.57	(4.08)	 8	(5-12)	 NA	 	
Anxiety	(GAD-7)	 5.33	(3.88)	 4.5	(3-7)	 NA	 	 	 3.86	(2.54)	 4	(2-5)	 NA		 	
Illness	perceptions	(BIPQ-
Total)		
48.89	(7.75)		 48.5	(3-7)	 	 	 	 39.86	(11.48)	 39	(31-50)	 	 	
Psychological	Distress			 	 	 	 	 	 	 	 	 	
Depression	(PHQ-9)	 7.11	(4.74)	 6.5	(4-8)	 7.5	(5.4)$	 7	(3-11.5)	 	 7.86	(4.06)	 7	(4-10)	 7.6	(4.7)	$	 8	(4-12)	
Anxiety	(GAD-7)	 4.78	(3.81)	 4	(1-7)	 4.4	(4.1)	$	 3.5	(1.5-6)	 	 4.86	(4.30)	 3	(1-8)	 3.9	(3.6)	$	 3	(1-5)	
QoL	Visual	Analogue	Scale			 58.94	(25.11)		 60	(50-77)	 61.1	(16.2)¶	 50	(50-71)	 	 56.29	(22.73)		 58	(42-81)	 56.2	(14.3)	¶	 55	(48-60)	
EQ5D	–	mood	 1.78	(0.88)	 2	(1-2)	 1.5	(0.8)	¶	 1	(1-2)	 	 1.71	(1.11)	 1	(1-2)	 2.0	(1.0)	¶	 2	(1-3)	
EQ5D	–	mobility	 2.28	(1.23)	 2	(1-3)	 1.5	(0.8)	¶	 1	(1-2	 	 2.14	(1.68)	 1	(1-4)	 2.4	(1.5)	¶	 2	(1-4)	
EQ5D	–	pain	 1.94	(1.35)	 1.5	(1-2)	 1.6	(0.8)	¶	 1	(1-2	 	 1.86	(1.21)	 1	(1-3)	 2.6	(1.3)	¶		 2	(2-4)	
EQ5D	-	self-care	 1.44	(0.70)	 1	(1-2)	 1.2	(0.6)	¶	 1	(1-2	 	 1.57	(0.79)	 1	(1-2)	 1.4	(0.9)	¶	 1	(1-1)	
EQ5D	-	usual	activities	 2.39	(1.24)	 2.5	(1-3)	 1.5	(0.8)	¶	 1	(1-2	 	 2.14	(1.07)	 2	(1-3)	 2.8	(1.3)	¶	 3	(2-4)	
Illness	perceptions	 	 	 	 	 	 	 	 	 	
BIPQ-Total	 45.33	(8.83)	 46	(42-51)	 44.2	(12.09)¥	 46	(38-53)	 	 41.86	(11.13)	 40	(29-50)	 41.2	(10.28)¶	 39	(36-46)	
BIPQ1.	Consequences	 8.94		(1.26)	 9.5	(8-10)	 7.9	(2.1)
	¥	 8	(6-10)	 	 7.85	(1.57)	 8	(6-9)	 7.2	(2.2)	¶	 8	(5-8)	
BIPQ2.	Timeline	 6.67	(2.77)	 6.5	(5-9)	 6.6	(3.6)	
¥	 8	(5-10)	 	 6.71	(3.35)	 8	(3-10)	 6.2	(4.8)	¶	 9	(2-10)	
BIPQ3.	Personal	control	 4.56	(2.79)	 4.5	(3-5)	 4.9	(3.1)
	¥	 4	(3-7)	 	 4.43	(2.99)	 4	(2-6)	 3.2	(2.4)	¶	 3	(2-5)	
BIPQ4.	Treatment	control	 1.44	(1.65)	 1	(0-2)	 2.3	(2.4)
	¥	 2	(0-5)	 	 1.57	(1.27)	 2	(0-3)	 2.0	(2.4)	¶	 1	(0-4)	
BIPQ5.	Identity	 5.78	(2.60)	 5.5	(4-8)	 5.6	(2.4)
	¥	 5	(4-8)	 	 6.29	(1.80)	 6	(3-8)	 8.0	(2.0)	¶	 9	(7-9)	
BIPQ6.	Concern	 8.50	(1.86)	 10	(7-10)	 7.4	(2.4)
	¥	 7	(5-10)	 	 6.42	(3.21)	 5	(4-10)	 8.0	(2.8)	¶	 10	(6-10)	
BIPQ7.	Understanding	 2.72	(2.65)		 2	(1-5)	 3.33	(2.4)
	¥	 2	(2-5)	 	 2.43	(1.72)	 2	(1-4)	 2.2	(2.6)	¶	 1(0-5)	
BIPQ8.	Emotional	response	 6.14	(2.27)		 7.5	(5-10)	 6.1	(2.8)
	¥	 6	(5-8)	 	 6.72	(3.30)	 7	(3-7)	 4.4	(4.0)	¶	 5	(1-6)	
Improving	Distress	in	Dialysis:	a	feasibility	RCT	–	AUTHOR	ACCEPTED	MANUSCRIPT	19/09/17	(UNCORRECTED	PROOF)	
30	
	
Key:	BIPQ,	Brief	Illness	Perception	Questionnaire;	EQ5D,	EuroQoL	scale,		GAD-7,	Generalised	Anxiety	Disorder;	N,	Number	of	patients;	NA,	Not	applicable;	PHQ-	9,	Patient	
Health	Questionnaire;	$,	N=16,	supported	arm	and	N=7,	unsupported	arm;	¶	N=13	supported	arm	and	N=	5	unsupported	arm;	¥=	N=	15	supported	arm.	
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Table	3:	Effect	size	estimates	for	primary	and	secondary	outcomes	at	12	week	follow-up		
Self-report	outcomes		
Estimated	
group	
difference	
(Supported	–	
Unsupported)1	
Standar
d	Error		
Cohen’s	
d2	
95%	
lower	
limit	
95%	
upper	
limit	
Psychological	Distress	
(N=23)		 	 	 	 	
	
Depression	(PHQ-9)	 0.70	 1.81	 0.14	 -0.75	 1.03	
Anxiety	(GAD-7)		 0.58	 1.78	 0.15	 -0.74	 1.04	
Quality	of	Life	(N=18)		 	 	 	 	 	
EQ5D	–	visual	
analogue	scale	 7.50	 8.47	 0.47	 -0.57	
1.51	
EQ5D	-	mood	 -0.40	 0.43	 -0.47	 -1.51	 0.57	
EQ5D	–	mobility	 -0.72	 0.42	 -0.71	 -1.76	 0.35	
EQ5D	-	pain	 -0.87	 0.48	 -0.92	 -1.99	 0.16	
EQ5D	-	self-care	 -0.20	 0.36	 -0.24	 -1.28	 0.79	
EQ5D	-	usual	
activities	 -1.32	 0.50	 -1.38	 -2.51	
-0.26	
Illness	perceptions	
(N=20)		 	 	 	 	 	
BIPQ:	Total	score	 2.22	 3.73	 0.19	 -0.83	 1.20	
BIPQ1.	Consequences	 0.40	 1.01	 0.19	 -0.85	 1.22	
BIPQ2.	Timeline	 1.35	 1.47	 0.34	 -0.69	 1.38	
BIPQ3.	Personal	
control	 1.71	 1.55	 0.58	 -0.47	 1.63	
BIPQ4.	Treatment	
control	 -0.14	 1.20	 -0.06	 -1.09	 0.97	
BIPQ5.	Identity	 -1.85	 1.06	 -0.80	 -1.82	 0.26	
BIPQ6.	Concern	 -1.75	 0.90	 -0.70	 -1.75	 0.36	
BIPQ7.	
Understanding	 1.12	 1.24	 0.46	 -0.59	 1.50	
BIPQ8.	Emotional	
response	 1.62	 1.48	 0.51	 -0.53	 1.56	
Key:	BIPQ,	Brief	Illness	Perception	Questionnaire;	EQ5D,	EuroQoL	scale,	GAD-7,	Generalised	Anxiety	
Disorder;	N,	Number	of	patients	included	in	complete	case	analysis;	NA,	Not	applicable;	PHQ-	9,	
Patient	Health	Questionnaire	1	Baseline	level	of	the	outcome	variable	is	equal	across	groups;	
2Positive	Cohen’s	d	value	indicates	that	the	mean	difference	was	higher	in	the	supported	arm	
compared	with	the	unsupported	arm
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Figure	1:	Stepped-care	referral	pathway	with	depression	and	anxiety	thresholds	used	for	onward	
referral	to	psychological	care		
*iDiD	intervention	with	or	without	telephone	support	
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Figure	2:	CONSORT	flow	diagram	
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Figure	legends:		
Figure	1:	Stepped-care	referral	pathway	with	depression	and	anxiety	thresholds	used	for	onward	
referral	to	psychological	care	
Figure	2:	Patient	flow	through	each	stage	of	the	study	
	
